These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10977933)

  • 1. Experimental models of Reye's syndrome.
    Saratikov AS; Vengerovskii AI; Arbuzov AG; Chuchalin VS; Chervyakova MB; Sukhodolo IV
    Bull Exp Biol Med; 2000 Apr; 129(4):400-2. PubMed ID: 10977933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of the features of Reye's syndrome in rats with 4-pentenoic acid.
    Glasgow AM; Chase HP
    Pediatr Res; 1975 Mar; 9(3):133-8. PubMed ID: 1121419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome.
    Kilpatrick LE; Polin RA; Douglas SD; Corkey BE
    Metabolism; 1989 Jan; 38(1):73-7. PubMed ID: 2909830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
    Abdin A; Sarhan N
    Can J Physiol Pharmacol; 2014 Sep; 92(9):780-8. PubMed ID: 25162205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvesicular fatty liver in rats with resembling Reye's syndrome induced by 4-pentenoic acid.
    Sakaida N; Senzaki H; Shikata N; Morii S
    Acta Pathol Jpn; 1990 Sep; 40(9):635-42. PubMed ID: 2260472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of hepatoprotectors in experimental Reye syndrome].
    Vengerovskiĭ AI; Sukhodolo IV; Chuchalin VS; Arbuzov AG; Cherviakova MB; Mel'nik IuIu; Grishina EI; Fedoreev SA; Saratikov AS
    Eksp Klin Farmakol; 2000; 63(5):68-71. PubMed ID: 11109534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
    Trost LC; Lemasters JJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1000-5. PubMed ID: 8819478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acids in an animal model of Reye's syndrome.
    Deshmukh DR; Deshmukh GD; Shope TC; Radin NS
    Biochim Biophys Acta; 1983 Sep; 753(2):153-8. PubMed ID: 6615853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aspirin a cause of Reye's syndrome? A case against.
    Orlowski JP; Hanhan UA; Fiallos MR
    Drug Saf; 2002; 25(4):225-31. PubMed ID: 11994026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of hepatitis A and adult Reye's syndrome.
    Duerksen DR; Jewell LD; Mason AL; Bain VG
    Gut; 1997 Jul; 41(1):121-4. PubMed ID: 9274483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine deficiency, hyperammonemia and Reye's syndrome in ferrets.
    Deshmukh DR; Thomas PE
    Lab Anim Sci; 1985 Jun; 35(3):242-5. PubMed ID: 2991654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome.
    Hart MA; Swisher JA; Caspers ML
    Biochem Pharmacol; 1989 May; 38(10):1696-8. PubMed ID: 2730684
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the pathophysiology of encephalopathy in Reye's syndrome; Hyperammonemia in Reye's syndrome.
    Shannon DC; De Long R; Bercu B; Glick T; Herrin JT; Moylan FM; Todres ID
    Pediatrics; 1975 Dec; 56(6):999-1004. PubMed ID: 1196768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disorders mimicking Reye's syndrome.
    Chang PF; Huang SF; Hwu WL; Hou JW; Ni YH; Chang MH
    J Formos Med Assoc; 2000 Apr; 99(4):295-9. PubMed ID: 10870312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute encephalopathy associated with centrilobular necrosis of liver mimicking Reye's syndrome--report of two cases].
    Lii YP; Chi SC; Mak SC
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Feb; 51(2):154-7. PubMed ID: 8385558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2.
    Hidaka T; Inokuchi T; Nakamura Y; Kotegawa M; Sugiyama M; Ogura R
    Exp Mol Pathol; 1991 Oct; 55(2):135-42. PubMed ID: 1936211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reye's syndrome in the United States from 1981 through 1997.
    Belay ED; Bresee JS; Holman RC; Khan AS; Shahriari A; Schonberger LB
    N Engl J Med; 1999 May; 340(18):1377-82. PubMed ID: 10228187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reye syndrome].
    Gladtke E; Schauseil-Zipf U
    Monatsschr Kinderheilkd; 1987 Oct; 135(10):699-704. PubMed ID: 3317005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
    Trost LC; Lemasters JJ
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.